Weiyun Ai: Clinical Trials

1 trial sponsored by Weiyun Ai, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Weiyun Ai: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma
Istodax, Doxil - Lymphoma, T-Cell Lymphoma
Phase 1CompletedWeiyun Ai242014-03-042020-06-09

Conditions studied

Lymphoma (1)  ·  Lymphoma, T-Cell (1)  ·  Lymphoma, T-Cell, Cutaneous (1)

Interventions

liposomal doxorubicin (1)  ·  romidepsin (1)

Countries

United States (1)

Top investigators

Ai Wei, M.D. (1)